DC Business DC
Viela Bio secures $75M Series B round. It's getting closer to bringing its lead candidate to market.
Gaithersburg's Viela Bio has completed a $75 million Series B round, bringing the total raised since the company's launch only 16 months ago to more than $350 million. The biotech…
